Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02993029 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

99Tc-MDP Treatment for Knee Osteoarthritis

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 30, 2025 to Dec 30, 2027v11
  2. Primary and study completion dates: Dec 30, 2024 to Dec 30, 2025v10
  3. Primary and study completion dates: Dec 30, 2023 to Dec 30, 2024v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary and study completion dates: Dec 30, 2021 to Dec 30, 2023v7
Show 5 earlier versionsHide 5 earlier versions
  1. Secondary endpoints: details revised at 1 of 4 entriesv6
  2. Primary and study completion dates: Dec 30, 2019 to Dec 30, 2021
    • Site contact updated
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Primary and study completion dates: Dec 2019 to Dec 30, 2019
    • Study site revised
    v3
  5. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date: Jan 2017 to Sep 1, 2017
    • Primary endpoint revised
    • Secondary endpoints revised (4)
    • Study site revised
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Osteoarthritis (OA) of knee is the most common form of arthritis in the world1e, and it has received growing attention in the society because of the increase of old age population, disabled people, and medical expenses from this disease. 99Tc-MDP is effective for rheumatoid arthritis. Therefore, the investigators try to investigate the effects of 99Tc-MDP treatment in patients with osteoarthritis of knee as compared with celecoxib.
Trial Details
NCT Number NCT02993029
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
(from sponsor)		 Treatment Outcome
Related terms Osteoarthritis
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov